Cargando…
Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy
In breast cancer patients who have received primary chemotherapy and then no longer have any suspicious lymph nodes clinically and/or on imaging, marking of initially suspicious axillary lymph nodes with targeted removal has recently been discussed and practised both in Germany and internationally a...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494517/ https://www.ncbi.nlm.nih.gov/pubmed/34629491 http://dx.doi.org/10.1055/a-1471-4234 |
_version_ | 1784579327319343104 |
---|---|
author | Hartmann, Steffi Stachs, Angrit Kühn, Thorsten de Boniface, Jana Banys-Paluchowski, Maggie Reimer, Toralf |
author_facet | Hartmann, Steffi Stachs, Angrit Kühn, Thorsten de Boniface, Jana Banys-Paluchowski, Maggie Reimer, Toralf |
author_sort | Hartmann, Steffi |
collection | PubMed |
description | In breast cancer patients who have received primary chemotherapy and then no longer have any suspicious lymph nodes clinically and/or on imaging, marking of initially suspicious axillary lymph nodes with targeted removal has recently been discussed and practised both in Germany and internationally as an alternative to complete axillary lymph node dissection. Tattooing of the suspicious lymph nodes with a highly purified carbon suspension is currently being investigated in clinical studies. Compared with other techniques, the advantages of this method are the high rate of intraoperative lymph node detection, avoidance of an immediately preoperative localisation procedure and the low costs. The practical aspects of lymph node tattooing and the current data regarding this method will be described. |
format | Online Article Text |
id | pubmed-8494517 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-84945172021-10-07 Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy Hartmann, Steffi Stachs, Angrit Kühn, Thorsten de Boniface, Jana Banys-Paluchowski, Maggie Reimer, Toralf Geburtshilfe Frauenheilkd In breast cancer patients who have received primary chemotherapy and then no longer have any suspicious lymph nodes clinically and/or on imaging, marking of initially suspicious axillary lymph nodes with targeted removal has recently been discussed and practised both in Germany and internationally as an alternative to complete axillary lymph node dissection. Tattooing of the suspicious lymph nodes with a highly purified carbon suspension is currently being investigated in clinical studies. Compared with other techniques, the advantages of this method are the high rate of intraoperative lymph node detection, avoidance of an immediately preoperative localisation procedure and the low costs. The practical aspects of lymph node tattooing and the current data regarding this method will be described. Georg Thieme Verlag KG 2021-10 2021-10-06 /pmc/articles/PMC8494517/ /pubmed/34629491 http://dx.doi.org/10.1055/a-1471-4234 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commecial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Hartmann, Steffi Stachs, Angrit Kühn, Thorsten de Boniface, Jana Banys-Paluchowski, Maggie Reimer, Toralf Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy |
title | Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy |
title_full | Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy |
title_fullStr | Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy |
title_full_unstemmed | Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy |
title_short | Targeted Removal of Axillary Lymph Nodes After Carbon Marking in Patients with Breast Cancer Treated with Primary Chemotherapy |
title_sort | targeted removal of axillary lymph nodes after carbon marking in patients with breast cancer treated with primary chemotherapy |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494517/ https://www.ncbi.nlm.nih.gov/pubmed/34629491 http://dx.doi.org/10.1055/a-1471-4234 |
work_keys_str_mv | AT hartmannsteffi targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy AT stachsangrit targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy AT kuhnthorsten targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy AT debonifacejana targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy AT banyspaluchowskimaggie targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy AT reimertoralf targetedremovalofaxillarylymphnodesaftercarbonmarkinginpatientswithbreastcancertreatedwithprimarychemotherapy |